Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2009 2
2010 2
2011 5
2012 3
2013 4
2014 10
2015 7
2016 9
2017 14
2018 10
2019 11
2020 12
2021 10
2022 8
2023 1
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
Compare and contrast: pediatric cancer versus adult malignancies.
Kattner P, Strobel H, Khoshnevis N, Grunert M, Bartholomae S, Pruss M, Fitzel R, Halatsch ME, Schilberg K, Siegelin MD, Peraud A, Karpel-Massler G, Westhoff MA, Debatin KM. Kattner P, et al. Among authors: karpel massler g. Cancer Metastasis Rev. 2019 Dec;38(4):673-682. doi: 10.1007/s10555-019-09836-y. Cancer Metastasis Rev. 2019. PMID: 31832830 Review.
Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma.
Torrini C, Nguyen TTT, Shu C, Mela A, Humala N, Mahajan A, Seeley EH, Zhang G, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Torrini C, et al. Among authors: karpel massler g. Mol Cell. 2022 Aug 18;82(16):3061-3076.e6. doi: 10.1016/j.molcel.2022.06.030. Epub 2022 Aug 9. Mol Cell. 2022. PMID: 35948010 Free PMC article.
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.
Nguyen TTT, Zhang Y, Shang E, Shu C, Torrini C, Zhao J, Bianchetti E, Mela A, Humala N, Mahajan A, Harmanci AO, Lei Z, Maienschein-Cline M, Quinzii CM, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Nguyen TTT, et al. Among authors: karpel massler g. J Clin Invest. 2020 Jul 1;130(7):3699-3716. doi: 10.1172/JCI129049. J Clin Invest. 2020. PMID: 32315286 Free PMC article.
Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma.
Nguyen TTT, Shang E, Westhoff MA, Karpel-Massler G, Siegelin MD. Nguyen TTT, et al. Among authors: karpel massler g. Cells. 2022 Sep 22;11(19):2956. doi: 10.3390/cells11192956. Cells. 2022. PMID: 36230918 Free PMC article. Review.
Cell death-based treatment of childhood cancer.
Westhoff MA, Marschall N, Grunert M, Karpel-Massler G, Burdach S, Debatin KM. Westhoff MA, et al. Among authors: karpel massler g. Cell Death Dis. 2018 Jan 25;9(2):116. doi: 10.1038/s41419-017-0062-z. Cell Death Dis. 2018. PMID: 29371599 Free PMC article. Review.
BET-inhibitors as sensitizers for BH3-mimetics.
Ishida CT, Karpel-Massler G, Siegelin MD. Ishida CT, et al. Among authors: karpel massler g. Aging (Albany NY). 2017 Jun 26;9(6):1475-1476. doi: 10.18632/aging.101259. Aging (Albany NY). 2017. PMID: 28657545 Free PMC article. No abstract available.
Novel IDH1-Targeted Glioma Therapies.
Karpel-Massler G, Nguyen TTT, Shang E, Siegelin MD. Karpel-Massler G, et al. CNS Drugs. 2019 Dec;33(12):1155-1166. doi: 10.1007/s40263-019-00684-6. CNS Drugs. 2019. PMID: 31768950 Free PMC article.
OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.
Nguyen TT, Torrini C, Shang E, Shu C, Mun JY, Gao Q, Humala N, Akman HO, Zhang G, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Nguyen TT, et al. Among authors: karpel massler g. JCI Insight. 2024 Mar 14;9(8):e172565. doi: 10.1172/jci.insight.172565. JCI Insight. 2024. PMID: 38483541 Free PMC article.
105 results